Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
Hua Medicine announced that its glucokinase activator dorzagliatin, marketed as MYHOMSIS®, received marketing approval from Hong Kong’s Department of Health under the “1+” regulatory pathway. The drug, the world’s first‑in‑class GKA, targets the root cause of glucose dysregulation in Type 2 diabetes and is already prescribed to over 200,000 patients in mainland China. Approval marks the first innovative chronic‑metabolic drug launched via Hong Kong’s “1+” mechanism, positioning the city as a launchpad for Hua Medicine’s expansion into Southeast Asia and global markets. The company will also pursue rollout in Macau and the Greater Bay Area.
Digital Tourniquets Could Soon Become First‑aid Essentials
Maybe it's not new, but that's the first time I saw a digital tourniquet. It is designed to help anyone quickly stop the bleeding. No training required. Just tighten, press, and save a life. This is the line companies like XMetix...
Do America’s Top Health Research Officials Stick Around Too Long?
Top officials at the National Institutes of Health (NIH) often serve open‑ended five‑year terms, with many directors remaining in post for a decade or more. Critics argue that such long tenures can stifle innovation, entrench soft power, and limit fresh...
News in Brief: Robotic Surgery Milestone at North Bristol, AI and RPA at Midlands Partnership, AI-Assisted Echocardiography in Cheshire and...
North Bristol NHS Trust performed its 10,000th robotic-assisted surgery, underscoring a decade of minimally invasive growth across multiple specialties. Meanwhile, Alder Hey Children’s NHS Foundation Trust expanded its 360° virtual tour to a full‑hospital map covering 313,585 square feet, helping...
Building Support Systems for Digital Health Innovators
Digital health innovators require structured support systems to move from concept to clinical impact. The article outlines how regulatory navigation, technical mentorship, education, and institutional ecosystems collectively reduce risk and accelerate product readiness. Early integration of quality, compliance, and clinician...
GLP-1 Drugs Linked to Lower Addiction Rates in Large Study of Veterans
A large retrospective study of over 600,000 U.S. veterans found that patients prescribed GLP-1 receptor agonists for diabetes were 14% less likely to develop new substance-use disorders compared with those on SGLT-2 inhibitors. The analysis also showed 30% fewer drug-related...
MIT Develops Biodegradable “Smart Pill” To Track Medication Adherence
MIT engineers have unveiled SAFARI, a biodegradable ingestible sensor that confirms pill ingestion using a bioresorbable Faraday cage and RFID tag. The device activates once the cage dissolves in the gastrointestinal tract and transmits a signal within about ten minutes....
Is Unified Communications Failing Healthcare Delivery?
Healthcare providers have poured resources into unified communications platforms such as Microsoft Teams, yet the majority of frontline clinicians remain underserved by devices that cannot survive rigorous hygiene protocols or unreliable wireless coverage. While administrative staff benefit from modern UC...
Personalized, Measurable, Flexible: The Next Generation of Digital Health Networks
Employers have layered dozens of digital health point solutions, creating a fragmented benefits landscape that confuses employees and burdens HR teams. Kris Heinzen argues that true value emerges when these tools are woven into a unified network that prioritizes personalization,...
Company Seeks to Become a ‘Leader in Interventional Radiology’ with Recent Acquisition
Quantum Surgical, a French robotics and AI specialist, has acquired Miami‑based NeuWave Medical from Johnson & Johnson, creating the Precision IO Group. The combined entity merges Quantum’s Epione platform for robotic‑assisted tumor ablation with NeuWave’s market‑leading microwave ablation devices used...
Keytruda Hangs On to Best Seller Crown as GLP-1s Gain Ground
Merck’s Keytruda remained pharma’s top‑selling drug in 2025, generating $31.7 billion and a 7 % year‑on‑year increase. However, the combined sales of GLP‑1 franchises—Eli Lilly’s tirzepatide line and Novo Nordisk’s semaglutide portfolio—totaled over $36 billion, overtaking Keytruda for the first time. The GLP‑1 market is...
Whole-Genome Sequencing Meets Real-World Outcomes: What 1,364 Breast Cancer Genomes Reveal About Treatment Response
A new Nature study sequenced the whole genomes of 1,364 breast cancers and linked the data to transcriptomics and real‑world treatment outcomes. The analysis showed that genome‑wide signatures such as homologous recombination deficiency, intratumoral heterogeneity, and copy‑number instability correlate with...
Mobile Skin Scans Hit Regional Aussies in New Campaign for Westfund and the Australian Skin Cancer Foundation via ABEL
ABEL, Westfund Health Insurance, and the Australian Skin Cancer Foundation have launched a national campaign offering free 3D mobile skin scans in regional Australia. The initiative brings world‑first 3D scanning technology directly to communities, removing cost and access barriers. Using...
Device Captures Brain Waves in Human‑Like Mini Brains
New Device Detects Brain Waves in Mini Brains Mimicking Early Human Development by @ShellyFan https://t.co/oMMhx9ux8Q https://t.co/6321RBopxf
Prediabetes or Diabetes Found in 1 in 3 Patients During Dental Appointment
King's College London researchers found that a chair‑side HbA1c finger‑prick test identified pre‑diabetes or diabetes in more than one‑third of dental patients without prior diagnosis. The study of 911 NHS patients linked higher HbA1c levels to greater severity of gum...
The February 2026 Compliance Deadline Is Here: Practical Steps for Substance Use Disorder Information Privacy Compliance
The U.S. Department of Health and Human Services and SAMHSA issued a February 2024 Final Rule that modernizes 42 C.F.R. Part 2, aligning substance‑use‑disorder (SUD) privacy with HIPAA while preserving heightened protections. Effective February 16 2026, the rule permits a single written consent for all treatment,...
EPA Pushes Back on Drinking Water Fluoridation Regulation
The EPA is contesting a Ninth Circuit panel’s view that a district judge overstepped by introducing new scientific studies in a case challenging federal fluoride standards. Food & Water Watch argues the EPA’s optimal fluoridation level poses an unreasonable risk...
Early Research Shows New Blood Test Can Help Predict Testicular Cancer Recurrence
Early-stage testicular cancer patients could soon benefit from a blood‑based assay that detects microscopic disease after orchiectomy. The CLIMATE study, led by WEHI and ANZUP, identified the microRNA marker miR‑371 as a reliable predictor of relapse, which occurs in roughly...
Alifor Launches Partnership with Piat, Study in Nigeria
Alifor announced a strategic partnership with Piat Public Health to embed implementation science into its AI‑driven clinical workflow platform. The collaboration will launch a six‑month study at General Hospital Lagos’ trauma centre, evaluating whether the system improves documentation, triage consistency,...
Novari Referral Tech Deployed at Niagara Health
Novari Health, a VitalHub company, is rolling out its Medical Imaging Requisition Management (MIRM) and eRequest referral platforms across all Niagara Health sites. The deployment adds an AI‑driven Document AI layer that auto‑populates data, detects multiple referrals, and verifies patient...
Montreal Heart Launches Simulation Centre
The Montreal Heart Institute (MHI) has opened the Centre for Advanced Simulation in Heart Valve Therapy, the first high‑fidelity valve simulation centre in the Americas. Acquired from Simulands, the platform supports training across transcatheter, repair and emerging minimally invasive procedures....
CHEO’s ThinkRare Algorithm Goes National
The CHEO Research Institute’s pediatric AI tool, ThinkRare, is moving beyond its home site to McMaster Children’s Hospital, Alberta Children’s Hospital and Stollery Children’s Hospital, marking one of Canada’s first national deployments of a real‑time, clinically embedded AI algorithm. ThinkRare...
EyePoint Inc (EYPT) Q4 2025 Earnings Call Transcript
EyePoint reported Q4 2025 results, highlighting rapid enrollment of over 900 patients in two pivotal wet AMD Phase 3 trials (Lugano and LUCHIA) with top‑line data expected mid‑2026. The company also initiated Phase 3 DME studies (COMO and CAPREIT) slated for first...
Cross Country Healthcare Inc (CCRN) Q4 2025 Earnings Call Transcript
Cross Country Healthcare reported Q4 2018 revenue of $200.9 million, down 9% year‑over‑year, and a net loss of $19.7 million. CEO Kevin Clark, a co‑founder, returned to lead a turnaround, eliminating the COO role and promoting internal leaders. The company...
Sight Sciences Inc (SGHT) Q4 2025 Earnings Call Transcript
Sight Sciences reported fourth‑quarter 2025 revenue of $20.4 million, a 7% year‑over‑year increase, driven by $19.7 million from interventional glaucoma and $0.7 million from the newly reimbursed interventional dry‑eye segment. Gross margins remained strong at 87% overall, while operating expenses fell 25% after...
Niagen Bioscience Inc (NAGE) Q4 2025 Earnings Call Transcript
Niagen Bioscience reported Q2 2025 revenue of $31.1 million, a 37% year‑over‑year increase, and lifted full‑year revenue guidance to 22‑27%. Gross margin improved to 65% driven by a higher‑margin sales mix and inventory efficiencies. The company expanded its Niagen Plus clinic...
Ardent Health Inc (ARDT) Q4 2025 Earnings Call Transcript
Ardent Health reported solid volume and revenue growth in Q3 2025, with revenue up 8.8% to $1.58 billion and adjusted EBITDA rising 46% to $143 million. However, the company lowered its full‑year adjusted EBITDA guidance to $530‑$555 million, citing accelerating professional‑fee expenses and...
Viemed Healthcare Inc (VMD) Q4 2025 Earnings Call Transcript
Viemed Healthcare reported a 14.7% year‑over‑year revenue increase in fiscal Q2 2025, driven entirely by organic growth across its core ventilation, sleep therapy, and resupply segments. Adjusted EBITDA rose 12% to $14.3 million, while SG&A fell to 45.7% of revenue, reflecting...
Oren Nissim, Brook-Ai – Figuring Out RPM
Brook.ai, led by CEO Oren Nissim, is scaling its remote patient monitoring (RPM) platform to cut hospital readmissions and improve care plan adherence. The company reports over 50% of its hypertension cohort achieving control within ten weeks and a roughly...
![[Viewpoint] Health Justice](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/50c5d03e6ed18ae6390998aec7eb49d6.webp)
[Viewpoint] Health Justice
The viewpoint piece separates health justice from the more commonly discussed health equity, arguing that the two concepts are often mistakenly merged. It highlights how decades of research on social determinants have produced a flood of studies documenting health gradients...
![[Comment] Considerations for Improving Non-Inferiority Trials](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/0f1a72bb75d13d20256f6082d5abd222.webp)
[Comment] Considerations for Improving Non-Inferiority Trials
Non‑inferiority trials are increasingly employed to evaluate new therapies that may offer advantages beyond efficacy, such as safety or convenience. However, their design and analysis present unique methodological challenges that can compromise study validity. The commentary outlines essential considerations, including...
Agentic Flocks To Healthcare Industry
LiveRamp announced the integration of Newton Research and SemantIQ agents into its data‑collaboration platform, allowing autonomous AI to handle audience creation, cross‑media measurement and spend optimization for health and life‑science marketers. Simultaneously, Doceree launched RepTwin and the Site LLM, a...
The Philippines: Digital Platform Boosts National Health Systems
SeeYouDoc, a Filipino health‑tech startup founded in 2018, has become a leading digital healthcare platform linking patients, clinicians, hospitals and local government units via web and mobile apps. The solution delivers telemedicine, digital prescriptions, electronic health records, appointment scheduling and...
New Zealand: Expanding AI Tools Across Healthcare
New Zealand has rolled out an artificial‑intelligence scribe tool across every emergency department, giving more than 1,250 clinicians automated note‑taking support. The pilot showed doctors could see an extra patient per shift, and post‑deployment surveys reported 80% of staff noting productivity...
Ripple Effects of 5-Star in Nursing Homes, and Why ‘Upstream’ Management Unlocks Higher Ratings
Nursing homes can boost their CMS Five‑Star ratings by adopting an "upstream" management approach that anticipates quality‑measure triggers before they occur. Operators are urged to analyze community trends, validate data, and engage interdisciplinary teams from admission through discharge. Proactive oversight...
Skilled Nursing Dealbook: Welltower-Affiliated Nursing Homes Sell for $82.4M; Multi-State Deal Secures $51.2M in Financing
Hill Valley Healthcare purchased two Virginia skilled‑nursing facilities from a Welltower affiliate for $82.4 million, marking the REIT’s exit from assets originally bought for under $15 million each. Capital Funding Group closed a $51.2 million bridge‑loan to acquire four multi‑state SNFs with 487...
TGA Seeks Public Feedback on New Manufacturing Rules for Medicines, Medicinal Gases
The Therapeutic Goods Administration (TGA) has launched two concept papers for public consultation, proposing revisions to PIC/S GMP Annex 6 for medicinal gases and Annex 15 for qualification and validation processes. The Annex 6 update seeks to reflect modern manufacturing technologies and computerized...
Grow Therapy Raises $150M to Expand Employer, Health System Partnerships
Grow Therapy announced a $150 million Series D round, bringing its total financing to $328 million. The round, led by TCV and Goldman Sachs Alternatives, will fund expansion into employer‑sponsored mental‑health benefits, deeper health‑system partnerships, and advanced AI tools for providers and patients....
Gut Health and Toxins Drive Parkinson’s Disease Surge
The gut and environmental toxins are key underpinnings of the Parkinson's disease pandemic @jclinicalinvest https://t.co/e8o4UuIafG https://t.co/7634Yg2Qo5
Eaton Bolsters Hospital Defenses as Healthcare Cybersecurity Act Arrives
Eaton announced a suite of infrastructure‑focused cybersecurity solutions to help hospitals comply with the Healthcare Cybersecurity Act of 2025. The portfolio includes network‑managed UPS systems, a gigabit Network M3 Card with secure boot and traffic filtering, and the Brightlayer digital power‑management...
FastFinance: Physician Unionizing Push; Trans Services Rules
Health systems are confronting an accelerating physician unionization movement, adding pressure to labor negotiations amid a broader wave of strikes. A new “Weird Number” reveals that 20 states now require minimum income thresholds for patients receiving free or discounted services,...
CMS Issues Toolkit on Behavioral Health Services for Children in Medicaid, CHIP
CMS has issued a new toolkit to help states improve behavioral health services for children covered by Medicaid and the Children’s Health Insurance Program. The guidance highlights early screening and intervention under EPSDT, care coordination, crisis response, telehealth, and workforce...
FBI Reminds of Potentially Malicious Activity by Iranian Cyber Actors
The FBI has issued a reminder to critical‑infrastructure operators to adopt mitigations outlined in a June 2025 fact sheet targeting Iranian‑affiliated cyber actors. These actors, motivated by ongoing geopolitical tensions, frequently exploit unpatched software, default passwords, and internet‑exposed operational technology (OT)...
Independent Medical Alliance Returns to Washington to Advance Patient and Parent-Centered Health Policy
The Independent Medical Alliance (IMA) returned to Washington, D.C. in early February 2026 for a series of meetings with senators, congressional staff, HHS officials and national media. Representing more than 12,000 clinicians across 35 specialties, IMA presented frontline clinical data...
GU26 Prostate Cancer Strategic Intelligence Report
Following strong interest in the ASH25 hematologic malignancy intelligence report, Biotech Strategy Blog released a new strategic intelligence series covering the ASCO GU meeting data on prostate, bladder, and renal cell cancers. The first installment focuses on advanced prostate cancer,...
Physicians Increasingly Targeted for Unionization
Physician unionization is accelerating as healthcare unions expand beyond nurses to target doctors. Membership of the intern‑resident‑fellow union more than doubled, reaching over 40,000 by 2025, and the new SEIU Doctors United group is launching a national campaign to organize...
Costs Loom Amid Evolving Trans Care Policies
Hospital groups and state attorneys general are urging the Centers for Medicare & Medicaid Services to withdraw two proposed rules that would ban gender‑affirming, or “sex‑rejecting,” procedures for minors and prohibit Medicaid and CHIP payments for such care. CMS estimates...
CISA Report Updates Findings on RESURGE Malware Attacks
CISA issued an updated analysis of RESURGE malware on February 26, expanding the agency’s 2024 findings about the threat targeting Ivanti Connect Secure devices. The report reveals that RESURGE can persist silently on compromised VPN appliances and stay dormant until...
New Report and Toolkit Offers States Strategies to Streamline HR 1 Implementation
Nonprofit design studio Civilla released a report and toolkit to help states rapidly adapt Medicaid eligibility systems to the new work‑requirement provisions of HR 1. The resources include user‑tested online application templates, policy guidance, and recommendations such as integrating work‑related questions...
FDA Approves First Generic of Flovent HFA for Treatment of Asthma
The FDA has approved the first generic version of Flovent HFA, a fluticasone propionate inhalation aerosol delivering 44 µg per actuation for asthma maintenance in patients aged four and older. The generic, produced by Glenmark Specialty SA, matches the brand’s safety and efficacy...